BIO-TECHNE Corp — Director's Dealing 2016

Aug 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-08-17

Reporting Person: LUCAS ROGER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-17	Common Stock	S	100	$113.70	Disposed	3415	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Optoin (right to buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016.

F2: Due to a mathematical error on the Form 4 filed May 9, 2016, the number of shares beneficially owned is being reduced by 100 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person.